BamSEC and AlphaSense Join Forces
Learn More

Dyne Therapeutics Inc. – Transcripts

NASDAQ: DYN    
Share price (9/29/26): $16.21    
Market cap (9/29/26): $3.027 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 09/14/26 Dyne Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 09:15 AM 09/14/26
Other Revised 03/09/26 Dyne Therapeutics, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-04-2026 11:50 AM 03/04/26
Other Revised 01/14/26 Dyne Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 05:15 PM 01/14/26
CY 2025
Other Revised 12/08/25 Dyne Therapeutics, Inc. - Special Call 12/08/25
Other Revised 09/08/25 Dyne Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-08-2025 09:15 AM 09/08/25
Other Revised 06/17/25 Dyne Therapeutics, Inc. - Special Call 06/17/25
Other Revised 01/15/25 Dyne Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 10:30 AM 01/15/25
Other Revised 01/21/25 Dyne Therapeutics, Inc. - Special Call 01/10/25
CY 2024
Other Revised 09/05/24 Dyne Therapeutics, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 04:05 PM 09/05/24
Other Revised 09/06/24 Dyne Therapeutics, Inc. - Special Call 09/03/24
Other Revised 05/20/24 Dyne Therapeutics, Inc. - Special Call 05/20/24
Other Revised 06/25/24 Dyne Therapeutics, Inc. Presents at Cantor Fitzgerald’s Virtual Muscular Dystrophy Symposium 2024, Apr-02-2024 09:50 AM 04/02/24